Working… Menu

Safety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02787109
Recruitment Status : Completed
First Posted : June 1, 2016
Last Update Posted : August 10, 2017
Imperial College London
Information provided by (Responsible Party):
Statens Serum Institut